The following posts are shamelessly stolen from Treeper “Bob,” who has provided many posts I have posted here that many of you have found vetty interdasting.
________________________________
Part 1 of 3
Starting with the realization that Moderna required time, money and effort to develop the mRNA product based on someone elses patents long before there was even a proven market for COVID-19 vaccine. One of the two critical patent claims was filed on March 5, 2018, and the other on January 9, 2019. As you will see, these patents belonged to Arbutus Biopharma Corporation.
How did Moderna know, that it needed a COVID-19 vaccine almost 2 years before it was needed?
Moderna has filed several inter parties reviews (IPRs), including against:
Arbutus Biopharma Corporation’s (Arbutus) U.S. Patent No. 9,404,127 (IPR2018-00680 filed February 21, 2018: all claims found unpatentable),
Arbutus’ U.S. Patent No. 9,364,435 (IPR2018-00739 filed March 5, 2018: claims 1-6, 9, 12, 14, and 15 found unpatentable),
Arbutus’ U.S Patent No. 8,058,069 (IPR2019-00554 filed January 9, 2019: no challenged claims found unpatentable),
Moderna has also filed oppositions in the European Patent Office (EPO), including against Arbutus’ EP2279254 (Opposition filed April 2018: amended claims corresponding to Auxiliary Request 1 accepted and revocation denied, pending appeal by Moderna.
__________________________
Part 2 of 3
Moderna Wants Fed. Cir. Help to Avoid Covid Vaccine Patent Suits
Oct. 6, 2021, 4:00 AM
Moderna Inc. subsidiary ModernaTX will ask the Federal Circuit at oral arguments Thursday to invalidate two patents it says could make its Covid-19 vaccine vulnerable to infringement suits.
The Patent Trial and Appeals Board upheld parts of Arbutus Biopharma Corp.’s U.S. Patent Nos. 9,364,435 and 8,058,069, on drug-delivery technology. Arbutus argues Moderna has no standing to appeal those decisions because Moderna hasn’t suffered any injury related to the patents.
While the CAFC said that Moderna succeeded in proving that it has a “substantial risk that Arbutus will assert the ’069 patent in an infringement suit targeting Moderna’s COVID-19 vaccine,” and thus had standing to appeal, the court ultimately said that Moderna’s obviousness theory was “an oversimplification based on unfounded assumptions.”
________________________________
Moderna Strikes Out at CAFC on Challenges to Arbutus Patents that May Pose a Risk to COVID Vaccines
By IPWatchdog
December 2, 2021
“Moderna falls short of its burden to demonstrate that at the time it filed this appeal, it had suffered or was suffering a ‘concrete’ injury from the existence of the ’435 patent.” – CAFC
___________________________
Note: DARPA is a Bioweapon developer for the U.S. Government!! What does the Vaccine contain, that is a Bioweapon, after all look at the money DARPA provided? Could it be COVID-19?
Moderna failed to disclose federal funding for vaccine patent applications, advocates say
By Ed Silverman Aug. 28, 2020
One particular patent assigned to Moderna concerns methods and compositions that can be used specifically against coronaviruses, including COVID-19. The patent names a Moderna scientist and a former Moderna scientist as inventors, both of which acknowledged performing work under the DARPA awards in two academic papers, according to the report by the advocacy group.
The group examined the 126 patents assigned to Moderna or ModernaTx as well as 154 patent applications. “Despite the evidence that multiple inventions were conceived in the course of research supported by the DARPA awards, not a single one of the patents or applications assigned to Moderna disclose U.S. federal government funding,” the report stated.
[UPDATE: A DARPA spokesman sent us this over the weekend: “It appears that all past and present DARPA awards to Moderna include the requirement to report the role of government funding for related inventions. Further, DARPA is actively researching agency awards to Moderna to identify which patents and pending patents, if any at all, may be associated with DARPA support. This effort is ongoing.”]
We asked Moderna for comment and will update you accordingly.
The missive to the Department of Defense follows a recent analysis by Public Citizen, another advocacy group, indicating the National Institutes of Health may own mRNA-1273, the Moderna vaccine candidate for Covid-19. The advocacy group noted the federal government filed multiple patents covering the vaccine and two patent applications, in particular, list federal scientists as co-inventors.
As for the Moderna vaccine, earlier this month, the company was awarded a $1.525 billion contract by the Department of Defense and the Department of Health and Human Services to manufacture and deliver 100 million doses of its Covid-19 vaccine. The agreement also includes an option to purchase another 400 million doses, although the terms were not disclosed.
https://www.statnews.com/pharmalot/2020/08/28/moderna-covid19-vaccine-coronavirus-patents-darpa/
____________________________
Without the two patents referenced below and made by Arbutus would the mRNA product even exist? And without the mRNA would the COVID-19 vaccine (light) even exist? Thereby making the patents filed by the government worthless.
***************************************
The missive to the Department of Defense follows a recent analysis by Public Citizen, another advocacy group, indicating the National Institutes of Health may own mRNA-1273, the Moderna vaccine candidate for Covid-19. The advocacy group noted the federal government filed multiple patents covering the vaccine and two patent applications, in particular, list federal scientists as co-inventors.
https://www.statnews.com/pharmalot/2020/08/28/moderna-covid19-vaccine-coronavirus-patents-darpa/
*****************************************************************
Starting with the realization that Moderna required time, money and effort to develop the mRNA product based on someone elses patents long before there was even a proven market for COVID-19 vaccine. One of the two critical patent claims was filed on March 5, 2018, and the other on January 9, 2019. As you will see, these patents belonged to Arbutus Biopharma Corporation.
How did Moderna know, that it needed a COVID-19 vaccine almost 2 years before it was needed?
Moderna has filed several inter parties reviews (IPRs), including against:
Arbutus Biopharma Corporation’s (Arbutus) U.S. Patent No. 9,404,127 (IPR2018-00680 filed February 21, 2018: all claims found unpatentable),
Arbutus’ U.S. Patent No. 9,364,435 (IPR2018-00739 filed March 5, 2018: claims 1-6, 9, 12, 14, and 15 found unpatentable),
Arbutus’ U.S Patent No. 8,058,069 (IPR2019-00554 filed January 9, 2019: no challenged claims found unpatentable),
Moderna has also filed oppositions in the European Patent Office (EPO), including against Arbutus’ EP2279254 (Opposition filed April 2018: amended claims corresponding to Auxiliary Request 1 accepted and revocation denied, pending appeal by Moderna.
__________________________
Note: If you want to thank Bob, here is the link to the last post here.
You don’t need an account on CT to post; you just need to a username and email
Troublemaker10
December 4, 2021 3:05 pm
Scott Adams
@ScottAdamsSays
These guys injected a disinfectant into sick COVID patients!
UV light was the disinfectant, injected via a light catheter.
Trump was right.
**********
Aytu BioScience Announces Completion of Healight(TM) Safety Study in Critically Ill COVID-19 Patients | BioSpace
___________________________________
joebkonobi
December 4, 2021 2:16 pm
Article rearding the success of Trump’s 2017 tax cuts. As always he delivered exactly what he promised. Me and my 401K miss him dearly.
“The fact is, Republicans’ 2017 tax reform law did exactly what was promised: It lowered taxes for all income groups, provided the greatest benefits for middle-income households, and spurred economic growth that helped reduce poverty and improve prosperity”.
_______________________
Colkitto
December 4, 2021 1:39 pm
Occult Ritual Transformation and Coronavirus: How Mask Wearing, Hand Washing, “Social Separation” and Lockdowns Are Age-Old Occult Rituals Being Used to Initiate People Into a New Global Order
https://haveyenotread.com/occult-ritual-transformation-and-coronavirus/
________________________
WhiteBoard
December 4, 2021 2:26 pm
Reply to R F Burns
my theory is the intel community is briefing world leaders on alien (AI, Deep Fake) communication and a coming planet etc…
the intel group simply uses fabricated information to convince the world leaders its inevitable.
(CERN, Climate Change, COVID, Borderless)
the aliens asked us to vaccinate the population so they wouldnt cause harm when we arrive. etc..
or some other version…
——
edit – the 4thbranch subverts all countries this way by recuiting all world leaders to a new Goal. and once they use those leaders to harm their own citizens, they next then harm those world leaders – subverting the entire Globe into Controllers and the Controlled Few Labor Masses
_________________________
WhiteBoard
December 4, 2021 1:18 pm
what are effective short information conveying messages that EACH OF US can do daily to do our part?
Example –
1) Post it of “Biden Didnt Win”
2) sticker of Joe saying “I did that” posted as gas stations, grocery aisles on cans etc
3) sticker – “theconservativetreehouse.com” – the last refuge
4) sticker – “The vaccine is 95% effective in increasing Pharma’s income”
make a running list, and lets get to work!
the news is NEVER going to save us, unless YOU (yes you specifically! become the news).
https://4thamendmentrestored.com/f/fight-on-the-field-of-language-its-a-thin-curtain-an-illusion
__________________________
newgamboge
December 4, 2021 11:54 am
Here in Maine, the gaslighting Bangor Daily News wants you to believe that the common cold is here with a “vengeance” and masking, social distancing and obsessive hand-washing are the way to go.
https://wgme.com/news/local/its-not-just-you-the-common-cold-is-worse-this-year
ThankQ CtC for the info!!
Another pingout !!!
https://freerepublic.com/focus/chat/4017404/posts?page=916#916
“
The following posts are shamelessly stolen from Treeper “Bob,” who has provided many posts I have posted here that many of you have found vetty interdasting.
________________________________
Part 1 of 3
Starting with the realization that Moderna required time, money and effort to develop the mRNA product based on someone elses patents long before there was even a proven market for COVID-19 vaccine. One of the two critical patent claims was filed on March 5, 2018, and the other on January 9, 2019. As you will see, these patents belonged to Arbutus Biopharma Corporation.
How did Moderna know, that it needed a COVID-19 vaccine almost 2 years before it was needed?
Moderna has filed several inter parties reviews (IPRs), including against:
Arbutus Biopharma Corporation’s (Arbutus) U.S. Patent No. 9,404,127 (IPR2018-00680 filed February 21, 2018: all claims found unpatentable),
Arbutus’ U.S. Patent No. 9,364,435 (IPR2018-00739 filed March 5, 2018: claims 1-6, 9, 12, 14, and 15 found unpatentable),
Arbutus’ U.S Patent No. 8,058,069 (IPR2019-00554 filed January 9, 2019: no challenged claims found unpatentable),
Moderna has also filed oppositions in the European Patent Office (EPO), including against Arbutus’ EP2279254 (Opposition filed April 2018: amended claims corresponding to Auxiliary Request 1 accepted and revocation denied, pending appeal by Moderna.
__________________________
Part 2 of 3
Moderna Wants Fed. Cir. Help to Avoid Covid Vaccine Patent Suits
Oct. 6, 2021, 4:00 AM
Moderna Inc. subsidiary ModernaTX will ask the Federal Circuit at oral arguments Thursday to invalidate two patents it says could make its Covid-19 vaccine vulnerable to infringement suits.
The Patent Trial and Appeals Board upheld parts of Arbutus Biopharma Corp.’s U.S. Patent Nos. 9,364,435 and 8,058,069, on drug-delivery technology. Arbutus argues Moderna has no standing to appeal those decisions because Moderna hasn’t suffered any injury related to the patents.
While the CAFC said that Moderna succeeded in proving that it has a “substantial risk that Arbutus will assert the ’069 patent in an infringement suit targeting Moderna’s COVID-19 vaccine,” and thus had standing to appeal, the court ultimately said that Moderna’s obviousness theory was “an oversimplification based on unfounded assumptions.”
________________________________
Moderna Strikes Out at CAFC on Challenges to Arbutus Patents that May Pose a Risk to COVID Vaccines
By IPWatchdog
December 2, 2021
“Moderna falls short of its burden to demonstrate that at the time it filed this appeal, it had suffered or was suffering a ‘concrete’ injury from the existence of the ’435 patent.” – CAFC
___________________________
Note: DARPA is a Bioweapon developer for the U.S. Government!! What does the Vaccine contain, that is a Bioweapon, after all look at the money DARPA provided? Could it be COVID-19?
Moderna failed to disclose federal funding for vaccine patent applications, advocates say
By Ed Silverman Aug. 28, 2020
One particular patent assigned to Moderna concerns methods and compositions that can be used specifically against coronaviruses, including COVID-19. The patent names a Moderna scientist and a former Moderna scientist as inventors, both of which acknowledged performing work under the DARPA awards in two academic papers, according to the report by the advocacy group.
The group examined the 126 patents assigned to Moderna or ModernaTx as well as 154 patent applications. “Despite the evidence that multiple inventions were conceived in the course of research supported by the DARPA awards, not a single one of the patents or applications assigned to Moderna disclose U.S. federal government funding,” the report stated.
[UPDATE: A DARPA spokesman sent us this over the weekend: “It appears that all past and present DARPA awards to Moderna include the requirement to report the role of government funding for related inventions. Further, DARPA is actively researching agency awards to Moderna to identify which patents and pending patents, if any at all, may be associated with DARPA support. This effort is ongoing.”]
We asked Moderna for comment and will update you accordingly.
The missive to the Department of Defense follows a recent analysis by Public Citizen, another advocacy group, indicating the National Institutes of Health may own mRNA-1273, the Moderna vaccine candidate for Covid-19. The advocacy group noted the federal government filed multiple patents covering the vaccine and two patent applications, in particular, list federal scientists as co-inventors.
As for the Moderna vaccine, earlier this month, the company was awarded a $1.525 billion contract by the Department of Defense and the Department of Health and Human Services to manufacture and deliver 100 million doses of its Covid-19 vaccine. The agreement also includes an option to purchase another 400 million doses, although the terms were not disclosed.
https://www.statnews.com/pharmalot/2020/08/28/moderna-covid19-vaccine-coronavirus-patents-darpa/
____________________________
Without the two patents referenced below and made by Arbutus would the mRNA product even exist? And without the mRNA would the COVID-19 vaccine (light) even exist? Thereby making the patents filed by the government worthless.
***************************************
The missive to the Department of Defense follows a recent analysis by Public Citizen, another advocacy group, indicating the National Institutes of Health may own mRNA-1273, the Moderna vaccine candidate for Covid-19. The advocacy group noted the federal government filed multiple patents covering the vaccine and two patent applications, in particular, list federal scientists as co-inventors.
https://www.statnews.com/pharmalot/2020/08/28/moderna-covid19-vaccine-coronavirus-patents-darpa/
*****************************************************************
Starting with the realization that Moderna required time, money and effort to develop the mRNA product based on someone elses patents long before there was even a proven market for COVID-19 vaccine. One of the two critical patent claims was filed on March 5, 2018, and the other on January 9, 2019. As you will see, these patents belonged to Arbutus Biopharma Corporation.
How did Moderna know, that it needed a COVID-19 vaccine almost 2 years before it was needed?
Moderna has filed several inter parties reviews (IPRs), including against:
Arbutus Biopharma Corporation’s (Arbutus) U.S. Patent No. 9,404,127 (IPR2018-00680 filed February 21, 2018: all claims found unpatentable),
Arbutus’ U.S. Patent No. 9,364,435 (IPR2018-00739 filed March 5, 2018: claims 1-6, 9, 12, 14, and 15 found unpatentable),
Arbutus’ U.S Patent No. 8,058,069 (IPR2019-00554 filed January 9, 2019: no challenged claims found unpatentable),
Moderna has also filed oppositions in the European Patent Office (EPO), including against Arbutus’ EP2279254 (Opposition filed April 2018: amended claims corresponding to Auxiliary Request 1 accepted and revocation denied, pending appeal by Moderna.
__________________________
Note: If you want to thank Bob, here is the link to the last post here.
You don’t need an account on CT to post; you just need to a username and email
“
AND
https://freerepublic.com/focus/chat/4017404/posts?page=920#920
“
Troublemaker10
December 4, 2021 3:05 pm
Scott Adams
@ScottAdamsSays
These guys injected a disinfectant into sick COVID patients!
UV light was the disinfectant, injected via a light catheter.
Trump was right.
**********
Aytu BioScience Announces Completion of Healight(TM) Safety Study in Critically Ill COVID-19 Patients | BioSpace
ALL 3 OF THE BOB POSTS
https://freerepublic.com/focus/chat/4017404/posts?page=923#923
“
Bob
December 4, 2021 11:54 am
Part 1 of 3
The SARS COV-2 Virus – November 2019
Dr. Martin: There, there there is no such thing as an Alpha or a Beta, or Gamma, or Delta variant. This is a, this is a means by which, what is desperately sought, is a degree to which individuals can be coerced into accepting something that they would not otherwise accept. There has not been in any of the published studies on what has been reportedly the Delta
variant, there has not been a “population are not calculated”, which is the actual replication rate. What has been estimated are computer simulations. But unfortunately if you look at GISAID, which is the public source of uploading any one of a number of variations, what you’ll find is that there has been no ability to identify any clinically altered gene sequence, which has then a clinically expressed variation. And this is the problem all along. This is the problem going back to the very beginning of what’s alleged to be a pandemic, is we do not have any evidence that the gene sequence alteration had any clinical significance whatsoever. There has not been a single paper, published by anyone, that has actually established that anything novel since, November of 2019, has clinical distinction from anything that predates November of 2019. The problem with the 73 patents that I described is that those 73 patents all contain what was ‘reported to be novel’, in December and January of, 2019 and 2020 respectively. So the problem is that even if we were to accept that there are idiopathic pneumonias, even if we were to accept that there are some set of pathogen induced symptoms, we do not have a single piece of published evidence that tells us that anything about the subclade SARS COV-2 has clinical distinction from anything that was known and published prior to November 2019 in 73 patents dating to 2008″.
Bob
December 4, 2021 11:55 am
Part 2 of 3
The Covid-19 Vaccine – March 2019
EXCLUSIVE: Covid Vaccine Patent Warned of Deliberate Coronavirus Release
09/07/2020
Link to Video
Newly unearthed documents from Moderna Pharmaceuticals Covid patent application include a claim of concern about a “deliberate release of SARS coronavirus” 9 months before the official emergence of Covid-19. In addition, it turns out that Moderna may not have the legal right to even release its vaccine in the next few weeks because the company appears to be infringing on an exisiting patent for the core technology. Is this why Moderna’s executives are selling their stock?
We have made it easy for the Big Tech Censors to find the source documents. Here the are:
US10702600B1
https://bit.ly/3bD3McU
March 2019 reference to the “deliberate release” of SARS
Application 16/368,270 and these four other applications:
https[COLON]//bit[DOT]ly/2DCdQ9E
https[COLON]//bit[DOT]ly/2R3xVsC
https[COLON]//bit[DOT]ly/323Nk2q
https[COLON]//bit[DOT]ly/325mcjp
Bob
December 4, 2021 11:56 am
Part 3 of 3
The Covid-19 Vaccine – March 2019
Because of a concern for reemergence or a deliberate release of the SARS coronavirus.
Moderna Pharmaceuticals Covid-19 patent application from March 2019 9 months before the official emergence of Covid-19, Includes a the following statement:
“[0011] Severe acute respiratory syndrome (SARS) emerged in China in 2002 and spread to other countries before brought under control. Because of a concern for reemergence or a deliberate release of the SARS coronavirus, vaccine development was initiated.”
This is not my emphasis this is how it actually appears in their application